These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 8851617

  • 1. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
    Kaatz GW, Seo SM.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):799-801. PubMed ID: 8851617
    [Abstract] [Full Text] [Related]

  • 2. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
    Mulazimoglu L, Drenning SD, Yu VL.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2428-30. PubMed ID: 8891159
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ, Cappelletty DM, Moldovan T, Aeschlimann JR, Kaatz GW.
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S, Chatzidimitriou M, Nikolaidis P, Tsona A, Bisiklis A, Kollaras P, Tsiakiri E, Koumentaki E, Alexiou-Daniel S.
    J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R, Rouse MS, Piper KE, Steckelberg JM.
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):119-22. PubMed ID: 10354862
    [Abstract] [Full Text] [Related]

  • 6. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
    LaPlante KL, Rybak MJ.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
    [Abstract] [Full Text] [Related]

  • 7. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
    Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):839-45. PubMed ID: 8849237
    [Abstract] [Full Text] [Related]

  • 8. Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Mathur T, Singhal S, Khan S, Bhateja P, Pandya M, Rattan A, Bhatnagar PK, Upadhyay DJ, Fatma T.
    J Chemother; 2008 Aug; 20(4):420-7. PubMed ID: 18676219
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C, Caillon J, Le Mabecque V, Miegeville AF, Donnio PY, Bugnon D, Potel G.
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [Abstract] [Full Text] [Related]

  • 10. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB, Lohray VB, Srivastava BK, Kapadnis PB, Pandya P.
    Bioorg Med Chem; 2004 Sep 01; 12(17):4557-64. PubMed ID: 15358283
    [Abstract] [Full Text] [Related]

  • 11. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar 01; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 12. In vitro activities of the oxazolidinone antibiotics U-100592 and U-100766 against Staphylococcus aureus and coagulase-negative Staphylococcus species.
    Jorgensen JH, McElmeel ML, Trippy CW.
    Antimicrob Agents Chemother; 1997 Feb 01; 41(2):465-7. PubMed ID: 9021209
    [Abstract] [Full Text] [Related]

  • 13. Enhanced activity of linezolid against Staphylococcus aureus in cerebrospinal fluid.
    Schwameis R, Fille M, Manafi M, Zeitlinger M, Sauermann R.
    Res Microbiol; 2012 Apr 01; 163(3):157-60. PubMed ID: 22210435
    [Abstract] [Full Text] [Related]

  • 14. In vitro evaluation of AZD2563, a novel oxazolidinone, against 603 recent staphylococcal isolates.
    Anderegg TR, Biedenbach DJ, Jones RN.
    Antimicrob Agents Chemother; 2002 Aug 01; 46(8):2662-4. PubMed ID: 12121951
    [Abstract] [Full Text] [Related]

  • 15. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.
    Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR.
    Antimicrob Agents Chemother; 1999 Aug 01; 43(8):2059-62. PubMed ID: 10428937
    [Abstract] [Full Text] [Related]

  • 16. Syntheses and antibacterial activity of a series of 3-(pyridine-3-yl)-2-oxazolidinone.
    Cui Y, Dang Y, Yang Y, Zhang S, Ji R.
    Eur J Med Chem; 2005 Feb 01; 40(2):209-14. PubMed ID: 15694656
    [Abstract] [Full Text] [Related]

  • 17. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J.
    Rev Esp Quimioter; 2005 Jun 01; 18(2):168-72. PubMed ID: 16130039
    [Abstract] [Full Text] [Related]

  • 18. The post-antibiotic effects of linezolid against Gram-positive pathogens.
    Hosgor-Limoncu M, Ermertcan S, Tasli H, Aydemir S.
    Saudi Med J; 2007 Apr 01; 28(4):551-4. PubMed ID: 17457476
    [Abstract] [Full Text] [Related]

  • 19. Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptible Staphylococcus aureus strains.
    Clark C, Kosowska-Shick K, McGhee P, Dewasse B, Beachel L, Appelbaum PC.
    Antimicrob Agents Chemother; 2009 Jul 01; 53(7):3118-21. PubMed ID: 19433566
    [Abstract] [Full Text] [Related]

  • 20. [Activity and penetration of linezolid and vancomycin against Staphylococcus epidermidis biofilms].
    Rodríguez-Martínez JM, Ballesta S, García I, Conejo MC, Pascual A.
    Enferm Infecc Microbiol Clin; 2007 Jul 01; 25(7):425-8. PubMed ID: 17692209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.